You are here: 
text zoom : S | M | L
Printer Friendly Version
Contact Details

The Robinson Institute
Ground Floor, Norwich Centre
55 King William Road
North Adelaide
SA 5006 Australia

Telephone: +61 8 8303 8166
Email

Placental Development

Research Leader: Associate Professor Claire Roberts

Clinical Leader: Professor Gus Dekker

The Placental Development group aims to identify pre-pregnancy and/or early gestation markers that have the ability to predict a couple's risk for the development of adverse pregnancy outcomes.

The group has identified factors that promote placental development and function and maternal adaptation to pregnancy that interact in determining pregnancy success. The group is part of the international SCOPE consortium, which is a multicentre trial that has currently recruited about 7000 couples around the world.

In Adelaide we recruited 1380 women to SCOPE, the last of whom delivered their babies in March 2009. In addition, the group has another smaller Adelaide-based clinical study: PAPO, Predicting Adverse Pregnancy Outcomes.

Research Priorities:

  • Identify single nucleotide polymorphisms (SNPs) that can be used to predict pregnancy outcome
  • Combine SNPs and develop a clinical test to identify couples at risk for pregnancy complications long before symptoms arise. This will enable appropriate antenatal care in both high risk and low risk settings
  • Perform cell culture work and elucidate the role of the particular genes of interested in trophoblast proliferation and function in order to understand their role in placentation
  • Identify circulating micronutrient factors, thrombophilias, hormones and lipids associated with adverse pregnancy outcome
  • Determine if DNA damage in sperm is correlated with DNA damage in peripheral lymphocytes
  • Determine if B-vitamins and SNPs are associated with DNA damage in either sperm or peripheral lymphocytes
  • Determine if DNA damage in mothers and fathers is associated with adverse pregnancy outcome
  • Determine that the polymorphisms we have identified have functional effects on gene expression in the placenta
  • Provide further proof-of-concept that our new embryo media formulation improves implantation rate, placental development and has no adverse effects on postnatal growth trajectory and reproductive potential of offspring

Follow Us

   

Visit Robinson Institute Blog

Summer 2012 Newsletter

In this issue; Improving heart health for women and their children, Dare to Dream gala dinner, uncovering the causes of stillbirth, silence for stroke success and more..

Download or read online

Funding Success

Congratulations to Robinson Institute researchers who were successful in receiving funding from the National Health & Medical Research Council.

Projects included a $1.9 million grant to investigate if magnesium sulphate given to women at risk of preterm birth can reduce the risk of death or cerebral palsy in their children.

Learn more

Annual Report

Enjoy reading about the achievements and milestones of the Robinson Institute and our researchers in our 2010 Annual Report.

Download Report

 

Evidense-Based Guidelines for Polycystic Ovary Syndrome

The Robinson Institute has been involved in the PCOS Australian Alliance to develop the world’s first evidence-based guideline for polycystic ovary syndrome (PCOS), a hormonal condition that affects approx 12% of reproductive aged women in Australia, yet up to 70% of women with PCOS remain undiagnosed.

Download Guidelines